Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Disulfides × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 14 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 5 Fallopian Tube Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Urogenital Neoplasms 2 Urethral Neoplasms 2 Ureteral Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mouth Neoplasms 2 Melanoma 2 Lymphoid Interstitial Pneumonia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colitis 2 Brenner Tumor 2 Brain Neoplasms 2 Adenocarcinoma, Mucinous 2 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05154994 2026-01-27

RESOLVE

University of Utah

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡